Lasa Supergenerics Limited (LASA.NS)
INR 17.46
(-0.96%)
INR 17.46
(-0.96%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -458 Million INR | 53.0% |
| 2022 | -180.98 Million INR | -481.26% |
| 2021 | 47.47 Million INR | -84.9% |
| 2020 | 314.41 Million INR | 101.77% |
| 2019 | 155.82 Million INR | 298.75% |
| 2018 | -78.4 Million INR | -133.91% |
| 2017 | 231.23 Million INR | -37.35% |
| 2016 | 369.09 Million INR | 0.0% |
| 2015 | - INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.96 Million INR | 85.0% |
| 2023 Q4 | -66.42 Million INR | -308.29% |
| 2023 FY | -85.06 Million INR | 53.0% |
| 2023 Q1 | 14 Million INR | 27.13% |
| 2023 Q3 | -16.26 Million INR | -4.68% |
| 2023 Q2 | -15.54 Million INR | -211.01% |
| 2022 Q3 | -46.92 Million INR | -36.77% |
| 2022 Q1 | -111.93 Million INR | -250.26% |
| 2022 FY | -180.98 Million INR | -481.26% |
| 2022 Q4 | 11.01 Million INR | 123.47% |
| 2022 Q2 | -34.31 Million INR | 69.35% |
| 2021 Q1 | 11.56 Million INR | -79.88% |
| 2021 FY | 47.47 Million INR | -84.9% |
| 2021 Q4 | 74.49 Million INR | 256.07% |
| 2021 Q3 | -47.73 Million INR | -117.02% |
| 2021 Q2 | -21.99 Million INR | -290.21% |
| 2020 Q3 | 84.66 Million INR | -3.04% |
| 2020 Q4 | 57.46 Million INR | -32.13% |
| 2020 FY | 314.41 Million INR | 101.77% |
| 2020 Q1 | 84.52 Million INR | 5.18% |
| 2020 Q2 | 87.31 Million INR | 3.3% |
| 2019 FY | 155.82 Million INR | 298.75% |
| 2019 Q4 | 80.36 Million INR | 113.3% |
| 2019 Q3 | 37.67 Million INR | 18.27% |
| 2019 Q2 | 31.85 Million INR | 314.21% |
| 2019 Q1 | 7.69 Million INR | 156.95% |
| 2018 Q3 | -55.01 Million INR | -292.16% |
| 2018 Q2 | -14.02 Million INR | -438.51% |
| 2018 Q1 | 4.14 Million INR | 107.12% |
| 2018 FY | -78.4 Million INR | -133.91% |
| 2018 Q4 | -13.5 Million INR | 75.45% |
| 2017 FY | 231.23 Million INR | -37.35% |
| 2017 Q1 | 131.16 Million INR | 0.0% |
| 2017 Q4 | -58.23 Million INR | -162.77% |
| 2017 Q2 | 82.97 Million INR | -36.74% |
| 2017 Q3 | 92.76 Million INR | 11.81% |
| 2016 Q1 | 94.02 Million INR | 0.0% |
| 2016 FY | 369.09 Million INR | 0.0% |
| 2015 FY | - INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hester Biosciences Limited | 364.77 Million INR | 225.56% |
| Albert David Limited | 1.33 Billion INR | 134.321% |
| Alembic Limited | 767.77 Million INR | 159.654% |
| Alkem Laboratories Limited | 19.46 Billion INR | 102.353% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 107.954% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | 292.714% |
| Bajaj HealthCare Limited | - INR | Infinity% |
| FDC Limited | 3.03 Billion INR | 115.097% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 105.101% |
| Gufic Biosciences Limited | 2.89 Billion INR | 115.827% |
| Hikal Limited | 1.49 Billion INR | 130.652% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 122.797% |
| Ind-Swift Limited | 1.22 Billion INR | 137.359% |
| Innova Captab Limited | 2.53 Billion INR | 118.079% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | 313.981% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 108.826% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | 320.142% |
| Laurus Labs Limited | 3.94 Billion INR | 111.599% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 124.026% |
| Lupin Limited | 27.75 Billion INR | 101.65% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | 1768.02% |
| Medico Remedies Limited | 277.11 Million INR | 265.274% |
| Morepen Laboratories Limited | 4.17 Billion INR | 110.973% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 111.772% |
| Orchid Pharma Limited | 2.36 Billion INR | 119.398% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 116.44% |
| RPG Life Sciences Limited | 2.29 Billion INR | 119.98% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 88.113% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 100.439% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 109.94% |
| Themis Medicare Limited | 1.3 Billion INR | 135.147% |
| Unichem Laboratories Limited | - INR | Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | 7376.851% |
| Venus Remedies Limited | 534.65 Million INR | 185.664% |
| Wanbury Limited | 1.7 Billion INR | 126.828% |
| Windlas Biotech Limited | 1.29 Billion INR | 135.261% |
| ZIM Laboratories Limited | 1.09 Billion INR | 141.708% |
| Ipca Laboratories Limited | 29.59 Billion INR | 101.547% |
| Aarti Drugs Limited | 7.14 Billion INR | 106.407% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 114.642% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | 2317.298% |
| Brooks Laboratories Limited | -72.25 Million INR | -533.899% |
| Eris Lifesciences Limited | 5.18 Billion INR | 108.839% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 109.267% |
| Sigachi Industries Limited | 1.47 Billion INR | 131.074% |
| Sakar Healthcare Limited | 495.5 Million INR | 192.432% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 100.438% |
| Divi's Laboratories Limited | 18.31 Billion INR | 102.501% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 110.237% |
| Mankind Pharma Limited | 40.86 Billion INR | 101.121% |
| Sequent Scientific Limited | - INR | Infinity% |
| Neuland Laboratories Limited | 5.31 Billion INR | 108.612% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 106.073% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 107.044% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 101.009% |
| Amrutanjan Health Care Limited | 621.02 Million INR | 173.75% |
| Wockhardt Limited | 140 Million INR | 427.146% |
| Bal Pharma Limited | 214.56 Million INR | 313.453% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 100.676% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 137.206% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | 183.034% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 106.339% |
| Shilpa Medicare Limited | 3.76 Billion INR | 112.176% |
| Valiant Laboratories Limited | - INR | Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 102.328% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | 16279.2% |
| Granules India Limited | 6.52 Billion INR | 107.016% |
| Medicamen Biotech Limited | - INR | Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | 283.753% |
| Piramal Enterprises Limited | - INR | Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 101.808% |
| NATCO Pharma Limited | 25.96 Billion INR | 101.764% |
| Suven Life Sciences Limited | -1.22 Billion INR | 62.637% |
| Krebs Biochemicals & Industries Limited | - INR | Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 108.764% |
| Indoco Remedies Limited | 1.52 Billion INR | 130.045% |
| Alpa Laboratories Limited | 61.51 Million INR | 844.542% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 88.87% |